PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+14.25%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.56B
AUM Growth
+$3.56B
(+18%)
Cap. Flow
+$344M
Cap. Flow
% of AUM
9.68%
Top 10 Holdings %
Top 10 Hldgs %
49.76%
Holding
165
New
31
Increased
30
Reduced
29
Closed
32
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$97.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$64.9M |
| 3 |
Ascendis Pharma
ASND
|
$64.3M |
| 4 |
VYNE Therapeutics
VYNE
|
$60.1M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$34.2M |
Top Sells
| 1 |
AnaptysBio
ANAB
|
$54M |
| 2 |
Neurocrine Biosciences
NBIX
|
$32.3M |
| 3 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$25.2M |
| 4 |
Intuitive Surgical
ISRG
|
$25M |
| 5 |
Zimmer Biomet
ZBH
|
$24.1M |
Sector Composition
| 1 | Healthcare | 96.13% |
| 2 | Consumer Discretionary | 0.06% |
| 3 | Industrials | 0.02% |
| 4 | Technology | 0.01% |
